U.S. markets close in 54 minutes

Vincerx Pharma, Inc. (VINC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.54+0.80 (+6.81%)
As of 3:02PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/1/2021
Current
3/31/2021
Market Cap (intraday) 5
232.15M269.90M
Enterprise Value 3
182.17M208.11M
Trailing P/E
N/AN/A
Forward P/E 1
N/AN/A
PEG Ratio (5 yr expected) 1
N/AN/A
Price/Sales (ttm)
N/AN/A
Price/Book (mrq)
9.094.92
Enterprise Value/Revenue 3
N/AN/A
Enterprise Value/EBITDA 7
-8.96-21.62

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 317.28%
S&P500 52-Week Change 331.46%
52 Week High 326.75
52 Week Low 39.95
50-Day Moving Average 313.69
200-Day Moving Average 316.90

Share Statistics

Avg Vol (3 month) 3151.78k
Avg Vol (10 day) 3129.07k
Shares Outstanding 517.52M
Implied Shares Outstanding 6N/A
Float 11.97M
% Held by Insiders 131.98%
% Held by Institutions 156.52%
Shares Short (Jul 14, 2021) 4748.7k
Short Ratio (Jul 14, 2021) 43.3
Short % of Float (Jul 14, 2021) 45.30%
Short % of Shares Outstanding (Jul 14, 2021) 44.27%
Shares Short (prior month Jun 14, 2021) 4460.5k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-22.89M
Diluted EPS (ttm)-3.08
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.35M
Total Cash Per Share (mrq)3.05
Total Debt (mrq)3.37M
Total Debt/Equity (mrq)13.20
Current Ratio (mrq)1.87
Book Value Per Share (mrq)1.74

Cash Flow Statement

Operating Cash Flow (ttm)-5.72M
Levered Free Cash Flow (ttm)N/A